Inclusion of currently diagnosed or treated individuals in studies of depression screening tool accuracy: a meta-research review of studies published in 2018-2021

Elsa-Lynn Nassar; Brooke Levis; Danielle B Rice; Linda Booij; Andrea Benedetti; Brett D Thombs

doi:10.1016/j.genhosppsych.2022.02.005

Inclusion of currently diagnosed or treated individuals in studies of depression screening tool accuracy: a meta-research review of studies published in 2018-2021

Gen Hosp Psychiatry. 2022 May-Jun:76:25-30. doi: 10.1016/j.genhosppsych.2022.02.005. Epub 2022 Feb 22.

Authors

Elsa-Lynn Nassar¹, Brooke Levis², Danielle B Rice³, Linda Booij⁴, Andrea Benedetti⁵, Brett D Thombs⁶

Affiliations

¹ Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
² Centre for Prognosis Research, School of Medicine, Keele University, Staffordshire, UK.
³ Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada.
⁴ Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Department of Psychology, Concordia University, Montreal, Quebec, Canada; CHU Sainte-Justine Hospital Research Centre, Montreal, Quebec, Canada.
⁵ Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada.
⁶ Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada. Electronic address: [email protected].

PMID: 35334411
DOI: 10.1016/j.genhosppsych.2022.02.005

Abstract

Objectives: Screening is done to improve health outcomes by identifying and effectively treating individuals with unrecognized conditions. Depression screening has been proposed to identify previously unrecognized depression cases. Including individuals already diagnosed or treated for depression in screening test accuracy studies could exaggerate accuracy and the yield of new cases from screening. The present study investigated (1) the proportion of depression screening tool accuracy primary studies published in 2018-2021 that excluded individuals with a confirmed depression diagnosis or who were already undergoing treatment; and (2) whether this has improved since the last review of studies published in 2013-2015, which found that five of 89 (5.6%) primary studies appropriately excluded such individuals.

Methods: MEDLINE was searched from January 1, 2018 through May 21, 2021 for primary studies on depression screening tool accuracy.

Results: Eighteen of 106 (17.0%; 95% Confidence Interval [CI], 11.0% to 25.3%) primary studies excluded currently diagnosed or treated individuals. This was 11.4% (95% CI, 2.8% to 20.0%) greater than in similar studies published in 2013-2015.

Conclusion: There has been an improvement since 2015, but the proportion of studies that exclude individuals already known to have depression remains low. This may bias research findings intended to inform clinical practice.

Keywords: Bias; Depression; Depression screening tools; Diagnostic test accuracy; Screening.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Depression* / diagnosis
Depression* / epidemiology
Depression* / therapy
Humans
Mass Screening*